BioSpace News Archive

DCprime, the front-runner in the field of relapse vaccines, in collaboration with the University of Bergen, today announced the presentation of a novel preclinical animal model tailored for cancer vaccine research at the virtual 25th European Hematology Association Congress (EHA).

Foundation Medicine, Inc., today announced that it has completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel multiomics liquid biopsy platforms to advance cancer care.

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that its Board of Directors has appointed Mark J. Golden as CEO effective August 17.

Hill Physicians Medical Group today announced it has received approval for a full-service restricted Knox-Keene license from the California Department of Managed Health Care (DMHC) for Sacramento County.

PANTHERx® Rare Pharmacy announces that it has been selected by Viela Bio, Inc. as their sole rare pharmacy partner for new drug Uplizna™ (inebilizumab-cdon).

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) tablets for oral suspension, which are used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type

Johnson & Johnson Consumer Health* today presented findings from the longest longitudinal study of infant and mother skin microbiome research at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020, from June 12 – 14, 2020.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new late-breaking Phase 3b head-to-head data showing superior rates of skin clearance for SKYRIZI® (risankizumab-rzaa) to COSENTYX®

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be a virtual exhibitor and have several delegates attending the DIA Global Annual Meeting and Virtual Conference taking place June 14-18th, 2020

Sorrento Therapeutics, Inc. announced that it prepaid in full its outstanding term loans on June 12, 2020.